机构:[1]Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.[2]Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, China.[3]Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.内科科室神经内科昆明医科大学附属第一医院[4]Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.[5]Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.[6]Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi, China.[7]Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
the National Natural Science Foundation of China (No.
U1903305 & 82160542), Key areas of the XPCC science and technology project (No. 2020AB022), International Science and Technology Cooperation Project of Science and Technology (No. 2022BC006), and Achievement transformation and Application promotion project of
Shihezi University (No. CGZH202006).
第一作者机构:[1]Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Sun Mengfei,Ma Yandi,Zhou Fuqiang,et al.A nine-gene signature with potential targets for predicting the prognosis of patients with esophageal cancer[J].Translational Cancer Research.2025,14(7):4305-4320.doi:10.21037/tcr-2025-146.
APA:
Sun Mengfei,Ma Yandi,Zhou Fuqiang,Xiang Quansheng,He Shangfeng...&Cui Xiaobin.(2025).A nine-gene signature with potential targets for predicting the prognosis of patients with esophageal cancer.Translational Cancer Research,14,(7)
MLA:
Sun Mengfei,et al."A nine-gene signature with potential targets for predicting the prognosis of patients with esophageal cancer".Translational Cancer Research 14..7(2025):4305-4320